NCT05921955

Brief Summary

The study propose that the using the high-flow nasl oxygen to provide oxygen for maternal can improve the fetal acidemia and the neonatal outcomes during cesarean section with combined spinal-epidural anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

January 26, 2024

Status Verified

April 1, 2023

Enrollment Period

6 months

First QC Date

June 15, 2023

Last Update Submit

January 25, 2024

Conditions

Keywords

high-flow nasal oxygencesarean sectionoxygenumbilical arteryacidemia

Outcome Measures

Primary Outcomes (1)

  • umbilical artery lactate, mmol/L

    mmol/L

    the fetal delivery

Secondary Outcomes (5)

  • umbilical artery pH value

    the fetal delivery

  • umbilical artery oxygen partial pressure(PO2)

    the fetal delivery

  • umbilical artery partial pressure of carbon dioxide(PCO2)

    the fetal delivery

  • umbilical artery base excess(BE), mmol/L

    the fetal delivery

  • the incidence of pH<7.20 and pH<7.10

    the fetal delivery

Study Arms (2)

air group

NO INTERVENTION

the patients of the air group receive the 2L/min with air pattern by the Optiflow high-flow nasal cannula system from anesthesia to fetal delivery.

HFNO group

EXPERIMENTAL

For HFNO group, a flow rate of 40L/min, with 100% oxygen concentration and a temperature of 37℃ by the Optiflow high-flow nasal cannula system from anesthesia to fetal delivery.

Device: Optiflow high-flow nasal cannula system

Interventions

Using the Optiflow high-flow nasal cannula system to supply oxygen for maternal.

HFNO group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • An elective cesarean section in Beijing Tongren Hospital
  • ≥37 weeks' gestation
  • American society of Aneshesiologists(ASA) I-III
  • Aged 18 to 45 years old
  • The fasting time is 6-8h, and the water restriction time is ≥2h
  • Anesthesia: combined spinal-epidural anesthesia
  • Agree to the study and sign the informed consent

You may not qualify if:

  • Fetal or placental abnormalities are known
  • Maternal has complications
  • Maternal BMI ≥40 kg/m2
  • History of difficult intubation or known difficult airway
  • Contraindications for HFNO such as nasal lesions or structural changes
  • Gastric reflux disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, 100000, China

Location

Related Publications (6)

  • Raghuraman N, Temming LA, Doering MM, Stoll CR, Palanisamy A, Stout MJ, Colditz GA, Cahill AG, Tuuli MG. Maternal Oxygen Supplementation Compared With Room Air for Intrauterine Resuscitation: A Systematic Review and Meta-analysis. JAMA Pediatr. 2021 Apr 1;175(4):368-376. doi: 10.1001/jamapediatrics.2020.5351.

    PMID: 33394020BACKGROUND
  • Qian G, Xu X, Chen L, Xia S, Wang A, Chuai Y, Jiang W. The effect of maternal low flow oxygen administration during the second stage of labour on umbilical cord artery pH: a randomised controlled trial. BJOG. 2017 Mar;124(4):678-685. doi: 10.1111/1471-0528.14418.

    PMID: 28224745BACKGROUND
  • Raghuraman N, Wan L, Temming LA, Woolfolk C, Macones GA, Tuuli MG, Cahill AG. Effect of Oxygen vs Room Air on Intrauterine Fetal Resuscitation: A Randomized Noninferiority Clinical Trial. JAMA Pediatr. 2018 Sep 1;172(9):818-823. doi: 10.1001/jamapediatrics.2018.1208.

    PMID: 30039159BACKGROUND
  • Zhou S, Cao X, Zhou Y, Xu Z, Liu Z. Ultrasound Assessment of Gastric Volume in Parturients After High-Flow Nasal Oxygen Therapy. Anesth Analg. 2023 Jul 1;137(1):176-181. doi: 10.1213/ANE.0000000000006340. Epub 2023 Jan 11.

    PMID: 36630297BACKGROUND
  • Zhou S, Zhou Y, Cao X, Ni X, Du W, Xu Z, Liu Z. The efficacy of high flow nasal oxygenation for maintaining maternal oxygenation during rapid sequence induction in pregnancy: A prospective randomised clinical trial. Eur J Anaesthesiol. 2021 Oct 1;38(10):1052-1058. doi: 10.1097/EJA.0000000000001395.

    PMID: 33259452BACKGROUND
  • Li YH, Lei GY, Guo J, Yi M, Fu YJ, Wang GY. Effect of maternal oxygen supplementation for parturient undergoing elective cesarean section by high-flow nasal oxygen compared with room air on fetal acidemia: study protocol for a randomized controlled trial. Trials. 2024 Jan 22;25(1):73. doi: 10.1186/s13063-024-07927-y.

Study Officials

  • guyan Wang

    Beijing Tongren Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2023

First Posted

June 27, 2023

Study Start

July 1, 2023

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

January 26, 2024

Record last verified: 2023-04

Locations